Literature DB >> 33557434

pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.

Suguru Yamamoto1, Kenichi Sasahara2, Mio Domon1, Keiichi Yamaguchi2, Toru Ito1, Shin Goto1, Yuji Goto2, Ichiei Narita1.   

Abstract

Protein-bound uremic toxins (PBUTs) are difficult to remove using conventional dialysis treatment owing to their high protein-binding affinity. As pH changes the conformation of proteins, it may be associated with the binding of uremic toxins. Albumin conformation at pH 2 to 13 was analyzed using circular dichroism. The protein binding behavior between indoxyl sulfate (IS) and albumin was examined using isothermal titration calorimetry. Albumin with IS, and serum with IS, p-cresyl sulfate, indole acetic acid or phenyl sulfate, as well as serum from hemodialysis patients, were adjusted pH of 3 to 11, and the concentration of the free PBUTs was measured using mass spectrometry. Albumin was unfolded at pH < 4 or >12, and weakened interaction with IS occurred at pH < 5 or >10. The concentration of free IS in the albumin solution was increased at pH 4.0 and pH 11.0. Addition of human serum to each toxin resulted in increased free forms at acidic and alkaline pH. The pH values of serums from patients undergoing hemodialysis adjusted to 3.4 and 11.3 resulted in increased concentrations of the free forms of PBUTs. In conclusion, acidic and alkaline pH conditions changed the albumin conformation and weakened the protein binding property of PBUTs in vitro.

Entities:  

Keywords:  albumin; indoxyl sulfate; isothermal titration calorimetry; pH; uremic toxins

Mesh:

Substances:

Year:  2021        PMID: 33557434      PMCID: PMC7914709          DOI: 10.3390/toxins13020116

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  20 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.

Authors:  G Mingrone; R De Smet; A V Greco; A Bertuzzi; A Gandolfi; S Ringoir; R Vanholder
Journal:  Clin Chim Acta       Date:  1997-04-04       Impact factor: 3.786

3.  Characterization of binding site of uremic toxins on human serum albumin.

Authors:  T Sakai; A Takadate; M Otagiri
Journal:  Biol Pharm Bull       Date:  1995-12       Impact factor: 2.233

4.  Structural basis of the drug-binding specificity of human serum albumin.

Authors:  Jamie Ghuman; Patricia A Zunszain; Isabelle Petitpas; Ananyo A Bhattacharya; Masaki Otagiri; Stephen Curry
Journal:  J Mol Biol       Date:  2005-10-14       Impact factor: 5.469

5.  Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.

Authors:  Hiroshi Watanabe; Tsuyoshi Noguchi; Yohei Miyamoto; Daisuke Kadowaki; Shunsuke Kotani; Makoto Nakajima; Shigeyuki Miyamura; Yu Ishima; Masaki Otagiri; Toru Maruyama
Journal:  Drug Metab Dispos       Date:  2012-04-18       Impact factor: 3.922

6.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

Review 7.  Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.

Authors:  Suree Lekawanvijit; Andrew R Kompa; Bing H Wang; Darren J Kelly; Henry Krum
Journal:  Circ Res       Date:  2012-11-09       Impact factor: 17.367

8.  Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.

Authors:  Suguru Yamamoto; Junichiro J Kazama; Kentaro Omori; Koji Matsuo; Yoshimitsu Takahashi; Kazuko Kawamura; Takayuki Matsuto; Hiroshi Watanabe; Toru Maruyama; Ichiei Narita
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

9.  Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia.

Authors:  Ahmed Al-Chalabi; Edouard Matevossian; Anne von Thaden; Catherine Schreiber; Peter Radermacher; Wolfgang Huber; Aritz Perez Ruiz de Garibay; Bernhard Kreymann
Journal:  Intensive Care Med Exp       Date:  2017-07-04

Review 10.  The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Authors:  Maryam Assem; Mathilde Lando; Maria Grissi; Saïd Kamel; Ziad A Massy; Jean-Marc Chillon; Lucie Hénaut
Journal:  Toxins (Basel)       Date:  2018-07-22       Impact factor: 4.546

View more
  3 in total

1.  Indoxyl sulfate impairs in vitro erythropoiesis by triggering apoptosis and senescence.

Authors:  Thitinat Duangchan; Manoch Rattanasompattikul; Narong Chitchongyingcharoen; Sumana Mas-Oodi; Moltira Promkan; Nuttawut Rongkiettechakorn; Suksan Korpraphong; Aungkura Supokawej
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-25

2.  In vitro assessment of the biocompatibility of chemically treated silicone materials with human lens epithelial cells.

Authors:  Elizabeth C Y Kao; Junghee Seo; David J McCanna; Lakshman N Subbaraman; Lyndon W Jones
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

3.  New Strategies for the Reduction of Uremic Toxins: How Much More We Know.

Authors:  Maria Teresa Rocchetti
Journal:  Toxins (Basel)       Date:  2021-11-24       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.